001     306666
005     20260209103941.0
024 7 _ |a 10.1097/MOU.0000000000001360
|2 doi
024 7 _ |a pmid:41318990
|2 pmid
024 7 _ |a 0963-0643
|2 ISSN
024 7 _ |a 1473-6586
|2 ISSN
037 _ _ |a DKFZ-2025-02659
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Reis, Henning
|b 0
245 _ _ |a Urachal cancer: a clinical, diagnostic, and therapeutic update.
260 _ _ |a London
|c 2026
|b Lippincott Williams & Wilkins
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1770629943_645158
|2 PUB:(DE-HGF)
|x Review Article
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a 2026 Mar 1;36(2):155-160
520 _ _ |a To give an overview of the advances in treatment, diagnosis, and epidemiological data of urachal tumors in 2024 and 2025.The update specifically refers to surgical approaches for localized cancers, drug therapy of advanced cancers, diagnostic criteria and consensus recommendations, diagnostic approaches, and epidemiological data.Recommendations for partial cystectomy (if feasible) in localized urachal adenocarcinomas helps to standardize therapeutic approaches. In addition, current clinical trial results and running studies will help to personalize treatment decisions in advanced disease. The ISUP Dublin consensus recommendations will facilitate the diagnostic process and research, as will the summarized, unbiased epidemiological data.
536 _ _ |a 899 - ohne Topic (POF4-899)
|0 G:(DE-HGF)POF4-899
|c POF4-899
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
650 _ 7 |a update
|2 Other
650 _ 7 |a urachal cancer
|2 Other
650 _ 7 |a urachal tumors
|2 Other
700 1 _ |a Szarvas, Tibor
|0 P:(DE-HGF)0
|b 1
700 1 _ |a Paner, Gladell P
|b 2
773 _ _ |a 10.1097/MOU.0000000000001360
|0 PERI:(DE-600)2026970-5
|n 2
|p 155-160
|t Current opinion in urology
|v 36
|y 2026
|x 0963-0643
909 C O |p VDB
|o oai:inrepo02.dkfz.de:306666
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 1
|6 P:(DE-HGF)0
913 1 _ |a DE-HGF
|b Programmungebundene Forschung
|l ohne Programm
|1 G:(DE-HGF)POF4-890
|0 G:(DE-HGF)POF4-899
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-800
|4 G:(DE-HGF)POF
|v ohne Topic
|x 0
914 1 _ |y 2025
915 _ _ |a Allianz-Lizenz
|0 StatID:(DE-HGF)0410
|2 StatID
|d 2025-01-02
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2025-01-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2025-01-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2025-01-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2025-01-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2025-01-02
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2025-01-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2025-01-02
920 1 _ |0 I:(DE-He78)ED01-20160331
|k ED01
|l DKTK Koordinierungsstelle Essen/Düsseldorf
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)ED01-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21